Jardiance vs. Trulicity

• Are Jardiance and Trulicity the Same Thing?
• What Are Possible Side Effects of Jardiance?
• What Are Possible Side Effects of Trulicity?
• What Is Jardiance?
• What Is Trulicity?
• What Drugs Interact with Jardiance?
• What Drugs Interact with Trulicity?
• How Should Jardiance Be Taken?
• How Should Trulicity Be Taken?

Jardiance (empagliflozin) and Trulicity (dulaglutide) are anti-diabetes medicines used as adjunctd to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Jardiance is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.

Side effects of Jardiance and Trulicity that are similar include weakness/lack of energy, low blood sugar (hypoglycemia), or nausea.

Side effects of Jardiance that are different from Trulicity include dehydration, dizziness, lightheadedness, yeast infection, upper respiratory tract infection, high cholesterol, joint pain, increased urination, urinary tract infection (UTI), thirst, and low blood pressure (hypotension).

Side effects of Trulicity that are different from Jardiance include diarrhea, frequent bowel movements, vomiting, abdominal pain or discomfort, decreased appetite, indigestion, fatigue, constipation, gas, bloating, gastroesophageal reflux disease (GERD), feeling unwell (malaise), or belching.

Jardiance may interact with diuretics and insulin or insulin secretagogues.

Trulicity may interact with other oral medications taken at the same time.

Common side effects of Jardiance include:

• dehydration,
• dizziness,
• lightheadedness,
• weakness,
• yeast infection,
• low blood sugar,
• nausea,
• upper respiratory tract infection,
• high cholesterol,
• joint pain,
• increased urination,
• urinary tract infection,
• thirst, and
• low blood pressure (hypotension).

Common side effects of Trulicity include:

• nausea,
• diarrhea,
• frequent bowel movements,
• vomiting,
• abdominal pain or discomfort,
• decreased appetite,
• indigestion,
• fatigue,
• constipation,
• gas,
• bloating,
• gastroesophageal reflux disease (GERD),
• weakness/lack of energy,
• feeling unwell (malaise),
• belching, and
• low blood sugar (hypoglycemia).

Jardiance (empagliflozin) is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2) used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Jardiance is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.

Trulicity (dulaglutide) is a human GLP-1 receptor agonist used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Jardiance may interact with diuretics, insulin or insulin secretagogues. Tell your doctor all medications and supplements you use. During pregnancy, Jardiance should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Trulicity may interact with other oral medications. Tell your doctor all medications and supplements you use. During pregnancy, Trulicity should be taken only if prescribed; it is unknown if it would affect a fetus. It is unknown if Trulicity passes into breast milk. Consult your doctor before breastfeeding.

The recommended dose of Jardiance is 10 mg once daily in the morning, taken with or without food.

The recommended initiating dose of Trulicity is 0.75 mg once weekly. The maximum recommended dose is 1.5 mg once weekly.